What is Dapa Met XR 10/1000mg?

Dapa Met XR 10/1000mg is a prescription once-daily combination anti-diabetic tablet containing Dapagliflozin 10mg and Metformin Extended-Release (XR) 1000mg. The 10mg dapagliflozin dose is the standard approved dose for cardiovascular and renal benefits (DAPA-HF, DAPA-CKD trials). The XR formulation of metformin ensures a controlled, gradual drug release throughout the day — providing equivalent glycaemic control to immediate-release metformin with significantly fewer gastrointestinal side effects and convenient once-daily dosing. Consult your doctor; prescription required.

How Does Dapa Met XR 10/1000mg Work?

Dapagliflozin 10mg inhibits SGLT-2 in the proximal renal tubule, blocking glucose reabsorption and causing approximately 70–80g of glucose daily to be excreted in urine. At the 10mg dose, dapagliflozin demonstrated a 26% relative risk reduction in the composite of CV death or worsening heart failure in the DAPA-HF trial, and a 39% relative risk reduction in the composite renal endpoint in the DAPA-CKD trial. Metformin XR activates AMPK to reduce hepatic glucose production and increase insulin sensitivity, releasing the drug gradually to avoid peak plasma concentrations that cause GI intolerance.

Uses of Dapa Met XR 10/1000mg

Indicated for adults with type 2 diabetes mellitus requiring dual therapy with dapagliflozin 10mg and metformin. The 10mg dapagliflozin dose is specifically recommended for patients with type 2 diabetes and established heart failure (reduced ejection fraction) or chronic kidney disease, where organ-protective benefits beyond glycaemic control are desired. Not for type 1 diabetes or diabetic ketoacidosis.

Dosage & Administration

Take Dapa Met XR 10/1000mg with the evening meal — taking with food improves metformin XR absorption and reduces GI effects; evening dosing aligns with XR kinetics for optimal overnight glucose control. One tablet once daily unless otherwise prescribed. Swallow whole with water — do not crush, split, or chew (this would destroy the extended-release matrix). Maintain adequate hydration. Monitor renal function before and during therapy. Prescription required.

Side Effects

Dapagliflozin-related: genital mycotic infections (thrush), urinary tract infections, osmotic diuresis, hypotension (volume depletion), rare diabetic ketoacidosis (DKA — stop and seek emergency care for nausea, vomiting, or fruity breath even with near-normal glucose), rare Fournier's gangrene. Metformin XR: substantially fewer GI effects than IR formulation — mild nausea or loose stools may still occur initially; rare but serious lactic acidosis (contraindicated when eGFR <30 mL/min/1.73m²).

Precautions

Metformin contraindicated in severe renal impairment (eGFR <30); hold 48 hours before and after iodinated contrast. Dapagliflozin sick-day rule: stop during acute illness, major surgery, or prolonged fasting to prevent euglycaemic DKA. Verify different GID from non-XR dapa-met products (confirmed: this product is GID 8355121004717). Monitor renal function, electrolytes, and blood pressure. Prescription required.

Frequently Asked Questions

Q: What is the difference between Dapa Met XR and Dapa Met (non-XR)?
A: The XR (extended-release) version releases metformin gradually over the day, allowing once-daily dosing and causing significantly fewer gastrointestinal side effects (nausea, diarrhoea) compared to the immediate-release formulation taken twice daily.

Q: Why does Dapa Met XR 10/1000mg contain 10mg of dapagliflozin instead of 5mg?
A: The 10mg dapagliflozin dose is the dose used in landmark trials (DAPA-HF, DAPA-CKD) that demonstrated cardiovascular and renal protective effects. It is the standard approved dose for these benefits in patients with heart failure or kidney disease.

Q: Can I break or cut the Dapa Met XR tablet?
A: No — the XR tablet must be swallowed whole. Cutting or crushing destroys the extended-release matrix, releasing the entire metformin dose at once and negating the benefits of the XR formulation.